Clinical Trial Update: A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II trial investigating neo-adjuvant gemcitabine, cisplatin, and bevacizumab in stage IIIA (N2) non-squamous non-small cell lung cancer; study terminated w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: NSCLC, Stage IIIA (N2) | Phase 2 | Status: TERMINATED | Results posted: 2012-08-21